These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30947191)

  • 1. Aminoglycoside Vestibulotoxicity.
    Rutka J
    Adv Otorhinolaryngol; 2019; 82():101-110. PubMed ID: 30947191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vestibulotoxicity: a risk of home aminoglycoside therapy.
    Saunders JE
    J Okla State Med Assoc; 2005 Dec; 98(12):596-600. PubMed ID: 16425609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vestibulotoxicity: strategies for clinical diagnosis and rehabilitation.
    Handelsman JA
    Int J Audiol; 2018 Sep; 57(sup4):S99-S107. PubMed ID: 29741128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unilateral vestibulotoxicity due to systemic gentamicin therapy.
    Waterston JA; Halmagyi GM
    Acta Otolaryngol; 1998 Jul; 118(4):474-8. PubMed ID: 9726669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vestibular and cochlear toxicity of aminoglycosides--a review.
    Nakashima T; Teranishi M; Hibi T; Kobayashi M; Umemura M
    Acta Otolaryngol; 2000 Oct; 120(8):904-11. PubMed ID: 11200584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ototoxicity of topical gentamicin preparations.
    Bath AP; Walsh RM; Bance ML; Rutka JA
    Laryngoscope; 1999 Jul; 109(7 Pt 1):1088-93. PubMed ID: 10401847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vestibular Hypofunction Secondary to Topical Use of Aminoglycosides in Ears with Perforated Tympanic Membrane.
    González-Aguado R; Veiga-Alonso A; Morales-Angulo C
    Audiol Neurootol; 2024; 29(5):425-428. PubMed ID: 38588647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoglycoside ototoxicity: Vestibular function is also vulnerable.
    Seemungal BM; Bronstein AM
    BMJ; 2007 Nov; 335(7627):952. PubMed ID: 17991943
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic Aminoglycosides-Induced Vestibulotoxicity in Humans.
    Van Hecke R; Van Rompaey V; Wuyts FL; Leyssens L; Maes L
    Ear Hear; 2017; 38(6):653-662. PubMed ID: 28650850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoglycoside-induced vestibular injury: maintaining a sense of balance.
    Ariano RE; Zelenitsky SA; Kassum DA
    Ann Pharmacother; 2008 Sep; 42(9):1282-9. PubMed ID: 18648019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permanent gentamicin vestibulotoxicity.
    Black FO; Pesznecker S; Stallings V
    Otol Neurotol; 2004 Jul; 25(4):559-69. PubMed ID: 15241236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycoside-induced ototoxicity.
    Selimoglu E
    Curr Pharm Des; 2007; 13(1):119-26. PubMed ID: 17266591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gentamicin vestibulotoxicity with modern systemic dosing regimens: a prospective study using video-oculography.
    Smyth D; Mossman S; Weatherall M; Jolliffe E; Joshi P; Taylor J; Thorne K; Watson E; Leadbetter R; Mossman B; Moss T; Todd N; Schneider E
    Acta Otolaryngol; 2019 Sep; 139(9):759-768. PubMed ID: 31311369
    [No Abstract]   [Full Text] [Related]  

  • 14. Gentamicin ototoxicity: a 23-year selected case series of 103 patients.
    Ahmed RM; Hannigan IP; MacDougall HG; Chan RC; Halmagyi GM
    Med J Aust; 2012 Jun; 196(11):701-4. PubMed ID: 22554194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycoside ototoxicity.
    Rizzi MD; Hirose K
    Curr Opin Otolaryngol Head Neck Surg; 2007 Oct; 15(5):352-7. PubMed ID: 17823553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of Ototoxicity and Otoprotection.
    Steyger PS
    Otolaryngol Clin North Am; 2021 Dec; 54(6):1101-1115. PubMed ID: 34774227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vestibulotoxicity in a patient without renal failure after inhaled tobramycin.
    Kaufman AC; Eliades SJ
    Am J Otolaryngol; 2019; 40(3):456-458. PubMed ID: 30910434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vestibulotoxicity following aminoglycoside antibiotics and its prevention.
    Darlington CL; Smith PF
    Curr Opin Investig Drugs; 2003 Jul; 4(7):841-6. PubMed ID: 14619406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A discussion of the dynamic illegible "E" test: a new method of screening for aminoglycoside vestibulotoxicity.
    Longridge NS; Mallinson AI
    Otolaryngol Head Neck Surg; 1984 Dec; 92(6):671-7. PubMed ID: 6440086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.